Our Tumor Response Service, grounded in the Tumor Response Assessment Criteria (TRAC), plays a role in the fight against cancer by tracking tumor progression and response to treatments. TRAC reports, derived from advanced 3D imaging measurements, provide a detailed medical imaging perspective on tumor changes over time through longitudinal analysis. This method collects data points across the treatment timeline, offering a comprehensive view of the tumor's reaction to therapy and guiding healthcare professionals in making informed adjustments to treatment plans.

When a TRAC report is requested, our technologists first establish a baseline by measuring the dimensions of target and non-target tumors from initial scans. Follow-up scans, typically conducted three months into treatment, allow for repeated measurements and the accumulation of data analyzed according to specific tumor response criteria, tailored to the cancer type and treatment regimen. The analysis results, securely stored within our system, are presented in various formats such as tabulated summaries, stacked charts, and galleries of snapshots from DICOM images, enabling a multifaceted view of the patient's cancer journey.

Standardized tumor response criteria serve as the foundation for these evaluations, creating a consistent framework for assessing how tumors shrink, disappear, remain stable, or grow in response to therapy. This structured approach supports healthcare providers in evaluating treatment effectiveness, making informed decisions on continuing, modifying, or seeking alternative treatments based on the unique nature of the cancer, the treatment strategy, and the evolving landscape of cancer therapies. Our service, through TRAC, empowers clinicians with precise insights to optimize patient outcomes in the complex fight against cancer.